Shenzhen JMMed Technology Co., Ltd est summus tech inceptum versantur in investigationis et progressionem, vestibulum et commercialization of peptides secundum products inter activae pharmaceutical ingredient, ut bene peptides medicamento progressionem. Jymed habet duas tota-owned subsidiaries: Shenzhen Jxbio pharmaceutical Co., Ltd et Hubei Jxbio Pharmaceutical Co, Ltd.
【R & D centrum】
Jymed est R & D centrum, in Shenzhen sita est in investigationis et progressionem novi medicamento substantiae, peptide apis et relevant products. In centro instructum est modern peptide synthesizer, magna-capacity praeparativa purificatio ratio, et comprehensive analytica instrumenta inter MS, Hplc, GC, UV Technology Support pro utroque Drents et Manufacturing Processus translationem.
【Productio bases】
Shenzhen jxbio situs est duo complevit dose biologicum productio lineas quod potest providere commercial batches of parva-capacity peptide injectables et rigida, exaruit pulveris products sub CGMP guidelines. Hubei jxbio site instructum est decem productio lineas ad peptide API productio et expanding magis, faciens illud unum de maxima peptide api vestibulum bases in Sinis.
JYMed has a complete and efficient peptide industrialization system, and can provide comprehensive peptide services, including CRO/CMO/CDMO/OEM and regulatory affairs support, enabling us to be your reliable, independent, and proactive supplier for your peptides!
【Key figuras de jymmed】
● CCCXV employees nationwide
● I RD Laboratories (Pingshan, Nanshan)
● II vestibulum facilities
● Apis, Xian'ning, Hubei, X productio lineas in obsequio cum FDA (sub constructione)
● Complevit Products, IV Dosis lineas in Shenzhen Pingshan, Guangdong
● VII Products Submitted Anda ad CFDA, V products in interponere
● I Product Submitted UD ad CFDA
● I Product Submitted VMF (US-FDA) et adeptus CEP certificatorium
【Factory Pictures】
JMED offert High Quality Peptide Apis, COLOR peptides, et CRO / CMO Services ex Research gradu ad CGMP gradu cum restrictius qualitas imperium, auxilium vobis eligere ius praesidium in vestri application.
